Seminal anti-Mullerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism | Zendy

Antonio Agostino Sinisi | Zendy; Dario Esposito | Zendy; Luigi Maione | Zendy; Maria Chiara Quinto | Zendy; Daniela Visconti | Zendy; Annamaria De Bellis | Zendy; Antonio Bellastella | Zendy; Giovanni Conzo | Zendy; Giuseppe Bellastella | Zendy

Open Access

Seminal anti-Mullerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism

Author(s) -

Antonio Agostino Sinisi,

Dario Esposito,

Luigi Maione,

Maria Chiara Quinto,

Daniela Visconti,

Annamaria De Bellis,

Antonio Bellastella,

Giovanni Conzo,

Giuseppe Bellastella

Publication year - 2008

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/den046

Subject(s) - anti müllerian hormone , medicine , spermatogenesis , endocrinology , gonadotropin , hypogonadotropic hypogonadism , testosterone (patch) , sperm , follicle stimulating hormone , hormone , andrology , biology , luteinizing hormone

In adult men, anti-Müllerian hormone (AMH) levels are higher in semen than in serum, but the significance and control of its seminal secretion are still unknown. This study evaluated seminal and serum AMH levels during long-term gonadotropin therapy in men with hypogonadotropic hypogonadism (HH).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research